Intervention Review

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

  1. Giovanni FM Strippoli1,*,
  2. Carmen Bonifati2,
  3. Maria E Craig3,
  4. Sankar D Navaneethan4,
  5. Jonathan C Craig5

Editorial Group: Cochrane Renal Group

Published Online: 18 OCT 2006

Assessed as up-to-date: 15 AUG 2006

DOI: 10.1002/14651858.CD006257


How to Cite

Strippoli GFM, Bonifati C, Craig ME, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006257. DOI: 10.1002/14651858.CD006257.

Author Information

  1. 1

    c) Diaverum Medical Scientific office, d) Mario Negri Sud Consortium, Italy, a) School of Public Health, University of Sydney, b) Cochrane Renal Group, Westmead, NSW, Australia

  2. 2

    University of Bari, Department of Emergency and Organ Transplanation, Bari, Italy

  3. 3

    University of New South Wales, Divison of Women's and Children's Health, Kogarah, NSW, Australia

  4. 4

    Glickman Urological and Kidney institute, Cleveland Clinic, Department of Nephrology and Hypertension, Cleveland, OH, USA

  5. 5

    (b) School of Public Health, The University of Sydney, (a) Cochrane Renal Group, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia

*Giovanni FM Strippoli, a) School of Public Health, University of Sydney, b) Cochrane Renal Group, c) Diaverum Medical Scientific office, d) Mario Negri Sud Consortium, Italy, Locked Bag 4001, Westmead, NSW, 2145, Australia. Giovanni.Strippoli@diaverum.com. strippoli@negrisud.it.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Robert Ekart, Anita Ferjuc, Barbara Furman, Špela Gerjevič, Sebastjan Bevc, Radovan Hojs, Chronic Kidney Disease Progression to End Stage Renal Disease: A Single Center Experience of the Role of the Underlying Kidney Disease, Therapeutic Apheresis and Dialysis, 2013, 17, 4
  2. 2
    Yuan-Mei He, Li Feng, Dong-Mei Huo, Zhen-Hua Yang, Yun-Hua Liao, Enalapril versus losartan for adults with chronic kidney disease: A systematic review and meta-analysis, Nephrology, 2013, 18, 9
  3. 3
    Jonathan Hewitt, Luis Castilla Guerra, María del Carmen Fernández-Moreno, Cristina Sierra, Diabetes and Stroke Prevention: A Review, Stroke Research and Treatment, 2012, 2012, 1

    CrossRef

  4. 4
    Catherine Akerman, Adam Kirk, Jonathan Hewitt, Diabetic renal disease in older people, Practical Diabetes, 2012, 29, 3
  5. 5
    Alan J. Sinclair, Giuseppe Paolisso, Marta Castro, Isabelle Bourdel-Marchasson, Roger Gadsby, Leocadio Rodriguez Mañas, European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary, Diabetes & Metabolism, 2011, 37, S27

    CrossRef

  6. 6
    Christos Milonas, Tomas Jernberg, Johan Lindbäck, Stefan Agewall, Lars Wallentin, Ulf Stenestrand, Effect of Angiotensin-Converting Enzyme Inhibition on One-Year Mortality and Frequency of Repeat Acute Myocardial Infarction in Patients With Acute Myocardial Infarction, The American Journal of Cardiology, 2010, 105, 9, 1229

    CrossRef

  7. 7
    Wehad H. Al Tourah, Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in prevention of nephropathy and cardiovascular disease in diabetics, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2008, 2, 2, 131

    CrossRef

  8. 8
    Anne Katrin Sjølie, Ronald Klein, Massimo Porta, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Nish Chaturvedi, Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial, The Lancet, 2008, 372, 9647, 1385

    CrossRef

  9. 9
    Raffaele De Caterina, Carmine Zoccali, Therapy in Nephrology & Hypertension, 2008,

    CrossRef

  10. 10
    Maarten W. Taal, Therapy in Nephrology & Hypertension, 2008,

    CrossRef

  11. 11
    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan, Giovanni FM Strippoli, Aldosterone antagonists for preventing the progression of chronic kidney disease, The Cochrane Library,
  12. 12
    Sankar D Navaneethan, Sagar U Nigwekar, Ashwini R Sehgal, Giovanni FM Strippoli, Aldosterone antagonists for preventing the progression of chronic kidney disease, The Cochrane Library,
  13. 13
    Sankar D Navaneethan, Sagar U Nigwekar, Giovanni FM Strippoli, Aldosterone antagonists for preventing the progression of chronic kidney disease, The Cochrane Library,
  14. 14
    Rachel C Blackburn, Claire L Parke, Pawana Sharma, Keith McCullough, Corri Black, Angiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non-diabetic chronic kidney disease, The Cochrane Library,
  15. 15
    Pawana Sharma, Rachel C Blackburn, Claire L Parke, Keith McCullough, Angharad Marks, Corri Black, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease, The Cochrane Library,
  16. 16
    Nicholas B Cross, Angela C Webster, Philip Masson, Philip J O'Connell, Jonathan C Craig, Antihypertensive treatment for kidney transplant recipients, The Cochrane Library,
  17. 17
    Vidhu Anand, Abhijit V Kshirsagar, Sankar D Navaneethan, Giovanni FM Strippoli, Nagendra Boopathy Senguttuvan, Sushil K Garg, Heejung Bang, Direct renin inhibitors for preventing the progression of diabetic kidney disease, The Cochrane Library,
  18. 18
    Wenlu Tang, Gavin WK Wong, Marco I Perez, James M Wright, First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension, The Cochrane Library,
  19. 19
    William Jr Cayley, In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?, Cochrane Clinical Answers,
  20. 20
    Sharon Reid, Peggy M Cawthon, Jonathan C Craig, Joshua A Samuels, Donald A Molony, Giovanni FM Strippoli, Non-immunosuppressive treatment for IgA nephropathy, The Cochrane Library,
  21. 21
    Hong Mei Wu, Hong Juan Sun, Feng Wang, Ming Yang, Bi Rong Dong, Guan J Liu, Oral adsorbents for preventing or delaying the progression of chronic kidney disease, The Cochrane Library,
  22. 22
    Han Wang, Jirong Yue, Jun Li, Yan Bin Hou, Jue Lin Deng, Rheum officinale (a Chinese medicinal herb) for chronic kidney disease, The Cochrane Library,
  23. 23
    Han Wang, Hongxian Song, Jirong Yue, Jun Li, Yan Bin Hou, Jue Lin Deng, Rheum officinale (a traditional Chinese medicine) for chronic kidney disease, The Cochrane Library,